Unusual computed tomography findings of radionecrosis after chemoradiation of stage IV hypopharyngeal cancer: a case report by Baba, Yuh et al.
CASE REPORT Open Access
Unusual computed tomography findings of
radionecrosis after chemoradiation of stage IV






Introduction: Radionecrosis (post-radiotherapy laryngeal submucosal inflammation and necrosis) is a complication
of (chemo) radiotherapy for hypopharyngeal cancer that is difficult to differentiate from tumor recurrence.
Case presentation: A 67-year-old Japanese man presented with a condition extremely difficult to diagnose
differentially as radionecrosis or tumor recurrence after radiotherapy for hypopharyngeal cancer. Although tumor
recurrence was suspected from clinical conditions and computed tomography findings, pathologic analysis
revealed no evidence of tumor recurrence, and successful therapy with steroids and antibiotics reduced the
mucosal edema.
Conclusion: Our findings emphasize the wide spectrum of radiographic presentation of radionecrosis after
chemoradiation of stage IV hypopharyngeal cancer.
Introduction
Adverse reactions to radiotherapy can include both early
and late complications. Late complications may arise
more than several months after the completion of radio-
therapy, even in patients who show no evidence of com-
plications during exposure. These complications are
generally irreversible, progress gradually, and cause cru-
cial organ dysfunction. Late radiotherapy complications
involving the head and neck area include disturbances
of salivary secretion, jaw necrosis, chondronecrosis,
hypothyroidism, subcutaneous tissue fibrosis, and devel-
opment of second cancers. Improvements in radiother-
apy seemed to have reduced the incidence of
radiotherapy-related adverse reactions, from 5% during
the 1970s to 1% during the 1990s [1,2]. Concomitant
chemoradiation has become widely used in patients with
advanced hypopharyngeal cancer, with an incidence of
adverse reactions that has been predicted to increase in
the future. To the best of our knowledge, however, few
reports are available about computed tomography (CT)
findings in patients with this condition [3,4]. We
describe here a patient who experienced radionecrosis
(post-radiotherapy laryngeal submucosal inflammation
and necrosis) after chemoradiation of stage IV hypo-
pharyngeal cancer, focusing on CT findings.
Case presentation
A 67-year-old Japanese man visited our department
complaining of pharyngeal pain. He had no appreciable
medical or family histories, had smoked 30 cigarettes
per day for 35 years, and had no drinking history. The
patient had become aware of pharyngeal pain and had
visited his general practitioner, but his condition did not
improve.
At his initial visit to our department, laryngopharyn-
geal fiberoptic endoscopy revealed a neoplastic lesion in
the left pyriform recess (Figure 1a). Vocal cord fixation
was also observed. Pathologic examination of a biopsy
specimen revealed a poorly differentiated squamous cell
carcinoma (SCC), and contrast CT showed a tumor
occupying the left pharyngeal cavity and infiltrating the
thyroid cartilage (Figure 1b). Lymph node metastasis in
the left side of the neck was confirmed, but no distant
metastases were found. The patient was diagnosed with
stage IVA hypopharyngeal cancer (T4aN2bM0) and
received two cycles of docetaxel, cisplatin, and
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weeks after neo-adjuvant chemotherapy, he was started
on concomitant chemoradiation, consisting of 10 mg/m
2
docetaxel on days 1, 8, 15, 22, and 29, and 3D radiother-
apy, consisting of 2Gy fractions once daily for five days
per week, for a total dose of 62.0Gy in 31 fractions. The
dose to the whole neck was 40.0Gy, and the dose to the
primary site was 62.0Gy. Although the patient com-
plained of mild pain in the throat, he was able to eat a
sufficient number of light meals.
At approximately one month after completing radio-
therapy, we took a biopsy sample of his left hypophar-
ynx under direct laryngoscopy to evaluate response to
therapy, as biopsy is done after initial treatment in the
UMCC (University of Michigan Comprehensive Cancer
Center) protocol 9520 [5]. Pathologic examination
showed no obvious presence of remaining tumor, and
CT showed no obvious neoplastic lesions (Figure 1c).
The patient recovered his pretreatment vocal cord fixa-
tion and achieved a pathologic complete response (CR).
Later, as an outpatient, he gradually developed phar-
yngeal pain and dyspnea. Laryngopharyngeal fiberoptic
endoscopy showed mucosal swelling in the pharynx and
larynx. CT images of his neck, taken approximately
eight months after the completion of radiotherapy,
revealed a suggestive space-occupying lesion in the right
lateral pharyngeal wall at the level of the epiglottis and a
suggestive circumferential space-occupying lesion in the
mucosa and airway constriction at the level of the thyr-
oid cartilage. In detail, CT scans showed mixed masses
of enhanced and non-enhanced lesions at both the epi-
glottis and thyroid-cartilage levels, strongly indicating
tumor recurrence. Although we observed swelling of the
surrounding soft tissues and segmentation or collapse of
the thyroid cartilage, we did not observe defluxion of
the arytenoid cartilage or abnormal gases contacting the
cartilage (Figure 2a,b). Dyspnea was gradually aggra-
vated, and the patient underwent a tracheostomy. Under
general anesthesia, we removed biopsy samples from his
lateral pharyngeal wall and larynx. Pathologic examina-
tion of these biopsy samples revealed no remaining can-
cer. Because the significant mucosal edema suggested
the possibility of undetected submucosal recurrent
lesions, we took additional biopsy samples under general
anesthesia, but pathologic examination again showed no
evidence of remaining cancer, although significant tissue
degeneration and necrosis were observed. After a tenta-
tive diagnosis of radionecrosis after radiotherapy, the
patient was treated with steroids and antibiotics. His lar-
yngeal edema and swelling in the right lateral pharyn-
geal wall improved gradually, resulting in significant
reductions in pharyngeal pain and pain during
Figure 1 Before and after chemoradiotherapy. (a) Fiberoptic
endoscopy showing a neoplastic lesion in the left pyriform recess.
(b) CT showing a tumor occupying the left pharyngeal cavity and
infiltrating the thyroid cartilage. (c) CT performed after the
completion of chemoradiotherapy, showing no evidence of
neoplastic lesions.
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Moreover, the space-occupying lesion, which had been
suspected as being tumor recurrence, had disappeared
(Figure 3a,b). After CT evaluation, the tracheostomy was
successfully reversed.
Two years after primary treatment with radiation, no
evidence has been found of tumor recurrence. The
patient’s speech and deglutition were preserved, and his
voice quality was within normal limits.
Discussion
Radionecrosis is one of the late complications of radio-
therapy. Although its incidence is approximately 1%
[1,2], it is predicted to increase because of the increasing
use of concomitant chemoradiotherapy. One possible
mechanism of pathogenesis is vasculitis-induced narrow-
ing and occlusion of the intravascular lumens [6].
Although radionecrosis usually occurs within the first
year after radiotherapy [7], it may occur more than ten
years later [8]. Treatment regimens for radionecrosis
include application of antibiotics and steroids, hyperba-
ric oxygen therapy, and surgical intervention [9].
The clinical manifestations of radionecrosis, including
hoarseness, difficulties with oral intake, pharyngeal pain,
dyspnea, and skin fistula, are similar to those of tumor
recurrence [10]. In addition, although radionecrosis is
frequently accompanied by various CT findings, includ-
ing swelling of the surrounding soft tissues, segmenta-
tion or collapse of the thyroid cartilage, defluxion of the
arytenoid cartilage, and abnormal gases in contact with
the cartilage, all of these findings are regarded as non-
specific [3,4]. Moreover, only about 50% of patients with
radionecrosis present with these CT findings [11]. CT
images of the neck of our patient revealed a suggestive
space-occupying lesion in the right lateral pharyngeal
wall at the level of the epiglottis and a suggestive cir-
cumferential space-occupying lesion in the mucosa and
airway constriction at the level of the thyroid cartilage.
In detail, CT scans showed mixed masses of enhanced
and non-enhanced lesions at both the epiglottis and
thyroid cartilage levels, masses that could have been
Figure 2 Follow-up CT results. (a) A suggestive space-occupying
lesion in the right lateral pharyngeal wall at the level of the
epiglottis, and (b) a suggestive circumferential space-occupying
lesion in the mucosa and airway constriction at the level of the
thyroid cartilage.
Figure 3 CT results after administration of steroids and
antibiotics. These show the disappearance of space-occupying
lesions initially suspected as tumor recurrence at the levels of the
(a) epiglottis and (b) thyroid cartilage.
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lesions were likely viable infectious cells, consistent with
the effectiveness of the antibiotics, whereas the non-
enhanced lesions were likely necrotic cells.
In addition to the similarity of clinical conditions and
CT findings in patients with radionecrosis and recurrent
lesions, some submucosal recurrent lesions may not be
detected by biopsy under direct laryngoscopy, especially
in patients with significant mucosal edema. Moreover,
in some patients, radionecrosis and recurrent tumor
may occur concurrently. Thus, differential diagnosis
between radionecrosis and tumor recurrence is consid-
ered extremely difficult. Positron emission tomography-
(PET)-CT is an alternative imaging modality that has
been successfully used to differentiate postradiation
changes, radionecrosis, and tumor recurrence. Further-
more, Fludeoxyglucose- (FDG)-PET scanning after
radiation can predict tumor regrowth three months later
[12]. However, follow-up PET-CT in our patient after
therapy yielded negative results (data not shown).
Patients with T3/T4 hypopharyngeal SCC usually
require total laryngopharyngectomy. Because our patient
initially had bulky stage IV disease, associated with frank
thyroid cartilage invasion, total laryngopharyngectomy
was applicable. However, the patient desired organ pre-
servation and therefore chose chemoradiotherapy as an
alternative to total laryngopharyngectomy [5]. As a result,
the patient retained appreciable vocal cord function of
speech and deglutition, and his prognosis was good at
two years after primary radiotherapy without tumor
recurrence. The return of vocal cord function after che-
moradiotherapy is a useful prognostic factor, with a five-
year overall survival rate in patients with recovered vocal
cord function of 100%, compared with a two-year overall
survival rate of patients with vocal cord fixation of less
than 40% [13]. Our patient recovered vocal cord fixation,
with no obvious signs of tumor recurrence more than
two years after initial chemoradiotherapy. Therefore, che-
moradiotherapy was appropriate for this patient.
Conclusions
A patient developed a condition after chemoradiother-
apy for hypopharyngeal cancer that required differential
diagnosis between radionecrosis and tumor recurrence.
Our findings emphasize the wide spectrum of radio-
graphic presentation of radionecrosis.
Consent
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